Ceftibuten

Ceftibuten

File:Ceftibuten.png
Identifiers
IUPAC name (6R,7R)-7-([(Z)-2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl]amino) -8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
CAS Number	97519-39-6
PubChem CID	5282242
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C15H14N4O6S2
Molar mass	410.427 g.mol-1

WikiDoc Resources for Ceftibuten
Articles
Most recent articles on Ceftibuten Most cited articles on Ceftibuten Review articles on Ceftibuten Articles on Ceftibuten in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Ceftibuten Images of Ceftibuten Photos of Ceftibuten Podcasts & MP3s on Ceftibuten Videos on Ceftibuten
Evidence Based Medicine
Cochrane Collaboration on Ceftibuten Bandolier on Ceftibuten TRIP on Ceftibuten
Clinical Trials
Ongoing Trials on Ceftibuten at Clinical Trials.gov Trial results on Ceftibuten Clinical Trials on Ceftibuten at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Ceftibuten NICE Guidance on Ceftibuten NHS PRODIGY Guidance FDA on Ceftibuten CDC on Ceftibuten
Books
Books on Ceftibuten
News
Ceftibuten in the news Be alerted to news on Ceftibuten News trends on Ceftibuten
Commentary
Blogs on Ceftibuten
Definitions
Definitions of Ceftibuten
Patient Resources / Community
Patient resources on Ceftibuten Discussion groups on Ceftibuten Patient Handouts on Ceftibuten Directions to Hospitals Treating Ceftibuten Risk calculators and risk factors for Ceftibuten
Healthcare Provider Resources
Symptoms of Ceftibuten Causes & Risk Factors for Ceftibuten Diagnostic studies for Ceftibuten Treatment of Ceftibuten
Continuing Medical Education (CME)
CME Programs on Ceftibuten
International
Ceftibuten en Espanol Ceftibuten en Francais
Business
Ceftibuten in the Marketplace Patents on Ceftibuten
Experimental / Informatics
List of terms related to Ceftibuten

Ceftibuten is a third-generation cephalosporin antibiotic. It is an orally-administered agent, with 2 dosage forms, capsule or oral suspension. It is marketed by Shionogi USA under the trade name Cedax®

Clinical use

Main article: Cephalosporin

Indications

Cefalexin is used to treat acute bacterial exacerbations of chronic bronchitis (ABECB), acute bacterial otitis media, pharyngitis, and tonsilitis.

Formulations

Ceftibuten is available as capsules containing 400 mg, and a powder for oral suspension containing 90 mg per 5 ml.

See also

• Cephalosporin

External links

• Manufacturer's website
• Drug information from RxList